InvestorsHub Logo
Followers 44
Posts 16100
Boards Moderated 0
Alias Born 09/16/2012

Re: None

Sunday, 06/12/2022 8:46:39 AM

Sunday, June 12, 2022 8:46:39 AM

Post# of 704246
Just so I have it right so far; This time around everyone is waiting a whopping two years for a peer reviewed publication to verify the five year old interim data that a half dozen physicians with close ties, claim looks promising. These physicians may or may not have financial interest in the company or the trial outcome, we just don't know as there's been no disclosure. The company has told investors that they are still currently shopping for a publication, so this could go on a while. The lead investigator and CEO appear to be MIA. All the trial information seems to be organized not on the company's own website but on the site of a guy named Al. And, as all this goes on, an astonishing 600,000,000 shares was added to the outstanding count in return for cash at an average 20 cents a share, providing the company's execs with great salaries and just enough cash to keep the lights on but no more. The company's lead product (Direct) has sat shelved for a decade. There's just about nothing left of cash or authorized shares. There is a manufacturing arm, but it's in the UK and shareholders have never once received revenue projections.

Do I have that right so far?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News